Prescription Drug Payment Commission, formed by the Catastrophic Care Act of 1988, will be disbanded Jan. 1, when the law is repealed. Rep. Levin (D-Mich.), who originated the concept of the commission last year, had attempted in the House/Senate conference on the repeal of the act to preserve the group by transforming it into a study commission. His attempt was unsuccessful and neither Levin nor any other member of Congress is currently interested in pursuing reauthorization of the group, according to Levin's office and RxPRC staff. RxPRC had been chaired by Alice Rivlin, Brookings Institution.
You may also be interested in...
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.